Edelsberg J - Search Results

1

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.

Weycker D, Malin J, Kim J, Barron R, Edelsberg J, Kartashov A, Oster G. Weycker D, et al. Among authors: edelsberg j. Clin Ther. 2009 May;31(5):1069-81. doi: 10.1016/j.clinthera.2009.05.019. Clin Ther. 2009. PMID: 19539108

2

Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?

Weycker D, Hackett J, Edelsberg JS, Oster G, Glass AG. Weycker D, et al. Among authors: edelsberg js. Ann Pharmacother. 2006 Mar;40(3):402-7. doi: 10.1345/aph.1G516. Epub 2006 Feb 21. Ann Pharmacother. 2006. PMID: 16492793

3

Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia.

Berger A, Edelsberg J, Kallich J, Oster G. Berger A, et al. Among authors: edelsberg j. Clin Ther. 2008 Jan;30(1):206-18. doi: 10.1016/j.clinthera.2008.01.004. Clin Ther. 2008. PMID: 18343258

4

Identification of patients receiving peritoneal dialysis using health insurance claims data.

Berger A, Edelsberg J, Inglese G, Bhattacharyya S, Oster G. Berger A, et al. Among authors: edelsberg j. Clin Ther. 2009 Jun;31(6):1321-34. doi: 10.1016/j.clinthera.2009.06.013. Clin Ther. 2009. PMID: 19695397

5

Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy.

Weycker D, Malin J, Barron R, Edelsberg J, Kartashov A, Oster G. Weycker D, et al. Among authors: edelsberg j. Am J Clin Oncol. 2012 Jun;35(3):267-74. doi: 10.1097/COC.0b013e31820dc075. Am J Clin Oncol. 2012. PMID: 21378538

6

Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice.

Weycker D, Barron R, Edelsberg J, Kartashov A, Lyman GH. Weycker D, et al. Among authors: edelsberg j. Breast Cancer Res Treat. 2012 May;133(1):301-10. doi: 10.1007/s10549-011-1949-5. Epub 2012 Jan 24. Breast Cancer Res Treat. 2012. PMID: 22270932

7

Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer.

Weycker D, Edelsberg J, Kartashov A, Barron R, Lyman G. Weycker D, et al. Among authors: edelsberg j. Chemotherapy. 2012;58(1):8-18. doi: 10.1159/000335604. Epub 2012 Feb 14. Chemotherapy. 2012. PMID: 22343254 Free article.

8

Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.

Weycker D, Barron R, Edelsberg J, Kartashov A, Legg J, Glass AG. Weycker D, et al. Among authors: edelsberg j. BMC Health Serv Res. 2014 Apr 27;14:189. doi: 10.1186/1472-6963-14-189. BMC Health Serv Res. 2014. PMID: 24767095 Free PMC article.

9

Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens.

Weycker D, Li X, Edelsberg J, Barron R, Kartashov A, Xu H, Lyman GH. Weycker D, et al. Among authors: edelsberg j. Support Care Cancer. 2014 Dec;22(12):3275-85. doi: 10.1007/s00520-014-2362-5. Epub 2014 Aug 1. Support Care Cancer. 2014. PMID: 25082364

10

Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.

Weycker D, Li X, Edelsberg J, Barron R, Kartashov A, Xu H, Lyman GH. Weycker D, et al. Among authors: edelsberg j. J Oncol Pract. 2015 Jan;11(1):47-54. doi: 10.1200/JOP.2014.001492. Epub 2014 Dec 9. J Oncol Pract. 2015. PMID: 25491042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters